Five-Year, Disease-Free Survival after Repeat Palliative Multimodality Therapy in a Patient with Recurrent Metastastic Bladder Cancer
In appropriately selected cases, palliative therapeutic strategies can be adapted to those special features of cancer biographies that indicate an atypical course of disease. Elucidating these features, and adapting multimodal treatment strategies to them, can lead to significantly superior effects...
Main Authors: | Sebastian Fetscher, Jan Schmielau, Wolfgang Schulze-Seemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2007-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2007.283 |
Similar Items
-
Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
by: Stephanie J Gros, et al.
Published: (2012-01-01) -
Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report
by: Benevento Raffaella, et al.
Published: (2012-11-01) -
Correction: Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
by: Stephanie J. Gros, et al.
Published: (2013-01-01) -
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma.
by: Fernanda Costa Svedman, et al.
Published: (2018-01-01) -
Correction: Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer.
by: Stephanie J. Gros, et al.
Published: (2013-01-01)